Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Earnings Release 2007

Aug 9, 2007

34595_rns_2007-08-09_d62d360a-a4b7-4347-ad68-b1ac1c176259.zip

Earnings Release

Open in viewer

Opens in your device viewer

8-K 1 v083470_8k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 9, 2007

| BIOANALYTICAL
SYSTEMS, INC. |
| --- |
| (Exact
name of registrant as specified in its
charter) |

Indiana 0-23357 35-1345024
(State
or other jurisdiction of incorporation or organization) (Commission
File Number) (I.R.S.
Employer Identification No.)

| 2701
KENT AVENUE WEST
LAFAYETTE, INDIANA | 47906-1382 |
| --- | --- |
| (Address
of principal executive offices) | (Zip
Code) |

Registrant's telephone number, including area code: (765) 463-4527

The information provided in Item 2.02 and Item 9.01 of this Form 8-K is being furnished and shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 and Item 9.01 of this Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

Item 2.02. Results of Operations and Financial Condition.

On August 9, 2007, Bioanalytical Systems, Inc. issued a press release announcing results for the third quarter of fiscal year 2007. The full text of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(a) Not applicable.

(b) Not applicable.

(c) Not applicable.

(d) Exhibits

99.1 Bioanalytical Systems, Inc. press release, issued August 9, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| /s/ Michael
R. Cox |
| --- |
| Michael
R. Cox |
| Vice
President, Finance and Chief Financial Officer |

Exhibit Index

Exhibit No. Description

99.1 Bioanalytical Systems, Inc. press release, issued August 9, 2007.